Bank Of America Corp Chroma Dex Corp. Transaction History

Bank Of America Corp

$1.19 Trillion
Q3 2024

A detailed history of Bank Of America Corp transactions in Chroma Dex Corp. stock. As of the latest transaction made, Bank Of America Corp holds 27,522 shares of CDXC stock, worth $205,314. This represents 0.0% of its overall portfolio holdings.

Number of Shares

27,522

Previous 24,803 10.96%

Holding current value

$205,314

Previous $67,000 49.25%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$2.51 - $3.8 $6,824 - $10,332	2,719 Added 10.96%	27,522 $100,000
Q2 2024 Aug 14, 2024	BUY	$2.44 - $4.32 $10,716 - $18,973	4,392 Added 21.52%	24,803 $67,000
Q1 2024 May 15, 2024	BUY	$1.36 - $3.84 $25,950 - $73,271	19,081 Added 1434.66%	20,411 $71,000
Q4 2023 Feb 14, 2024	SELL	$1.28 - $1.6 $6,361 - $7,952	-4,970 Reduced 78.89%	1,330 $1,000
Q2 2023 Aug 14, 2023	SELL	$1.31 - $1.79 $13,321 - $18,202	-10,169 Reduced 61.75%	6,300 $9,000
Q1 2023 May 12, 2023	BUY	$1.48 - $2.19 $13,795 - $20,412	9,321 Added 130.4%	16,469 $25,000
Q4 2022 Feb 10, 2023	SELL	$1.25 - $1.94 $33,130 - $51,417	-26,504 Reduced 78.76%	7,148 $12,000
Q3 2022 Nov 14, 2022	BUY	$1.19 - $2.06 $184 - $319	155 Added 0.46%	33,652 $42,000
Q2 2022 Aug 12, 2022	SELL	$1.59 - $2.7 $1.21 Million - $2.05 Million	-759,054 Reduced 95.77%	33,497 $55,000
Q1 2022 May 16, 2022	SELL	$2.02 - $3.92 $1.27 Million - $2.47 Million	-629,808 Reduced 44.28%	792,551 $1.95 Million
Q4 2021 Feb 08, 2022	SELL	$3.74 - $6.7 $32,306 - $57,874	-8,638 Reduced 0.6%	1,422,359 $5.32 Million
Q3 2021 Nov 15, 2021	BUY	$6.05 - $10.41 $1.43 Million - $2.45 Million	235,656 Added 19.71%	1,430,997 $8.97 Million
Q2 2021 Sep 13, 2021	BUY	$6.66 - $10.92 $7.96 Million - $13.1 Million	1,195,341 New	1,195,341 $11.8 Million

Others Institutions Holding CDXC

# of Institutions

Shares Held

17.2M

Call Options Held

66.7K

Put Options Held

8.2K

View Full List

About ChromaDex Corp.

Ticker CDXC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,350,896
Market Cap $510M
Description
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...

More about CDXC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Chroma Dex Corp. Transaction History